Core Viewpoint - The article highlights the swift action taken by the Xiamen Market Supervision Administration in response to reports of false advertising related to "imported" blood sugar control drinks, leading to the removal of certain products from the market and ongoing investigations into the involved companies [1][4][5]. Regulatory Response - The Xiamen Market Supervision Administration has initiated an investigation into the companies involved in the false advertising of blood sugar control products, specifically targeting the "Kongtangwei" and "Breorqy" brands [1][5]. - The regulatory body has mandated the removal of product links and is conducting further investigations to address the reported violations [1][5][6]. Market Impact - The article notes that the false claims made by these products, such as being "imported" and having extraordinary effects on blood sugar control, misled consumers and posed challenges to diabetes treatment [4][5]. - The cost of the "Kongtangwei" product is estimated to be less than 10 yuan, while it is sold for over 100 yuan, indicating significant markup based on misleading claims [4]. Ongoing Issues - Despite the removal of certain products, many others continue to be sold with unchanged promotional content, indicating a persistent issue with false advertising in the market [7][8]. - The article points out that various other products, including chromium supplements and herbal teas, also make unverified claims regarding their effectiveness in controlling blood sugar levels [5][8]. Recommendations for Improvement - Experts suggest that regulatory efforts need to be strengthened, particularly in enhancing the oversight of e-commerce platforms to prevent the sale of products with exaggerated claims [8][9]. - There is a call for improved collaboration among regulatory bodies across different regions to ensure comprehensive monitoring and enforcement against misleading advertising practices [8][9].

Core Viewpoint - The article highlights the issue of false advertising in fish oil products sold through live streaming, prompting regulatory actions from the State Administration for Market Regulation (SAMR) in China [1] Regulatory Actions - SAMR has initiated enforcement checks in provinces including Anhui, Shanghai, Zhejiang, and Guangdong in response to the reported false claims regarding fish oil products [1] - Three specific non-compliant fish oil products were identified: "Huacheng·Astaxanthin Deep Sea Fish Oil Gummy Candy," "Huacheng·Deep Sea Polyunsaturated Fish Oil Gummy Candy," and "Deep Sea Polyunsaturated Fish Oil (Sugar-Free) Gummy Candy" [1] - The Anhui market regulatory department conducted immediate inspections on the involved companies, leading to investigations against Anhui Gusu Yuan Pharmaceutical Co., Ltd. and Anhui Runfeng Health Technology Co., Ltd. [1] Legal Violations - The companies are being investigated for potential violations of the Food Safety Law of the People's Republic of China and the Anti-Unfair Competition Law [1] - Local market regulatory authorities have engaged with platform representatives to address the illegal product listings, and false advertising cases have been referred to relevant market regulatory departments for legal action [1]